Long-term morphine treatment decreases the association of μ-opioid receptor (MOR1) mRNA with polysomes through miRNA23b

Molecular Pharmacology

Volumn 75, Issue 4, 2009, Pages 744-750

  Wu, Qifang ^a   Zhang, Lei ^a   Law, Ping Yee ^a   Wei, Li Na ^a   Loh, Horace H ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; MICRORNA; MICRORNA 23B; MORPHINE; MU OPIATE RECEPTOR; TRANS ACTING FACTOR; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; LONG TERM CARE; NONHUMAN; POLYSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA TRANSLATION;

ANIMALS; CELL LINE; HUMANS; LUCIFERASES, RENILLA; MICE; MICRORNAS; MORPHINE; POLYRIBOSOMES; PROTEIN BINDING; RECEPTORS, OPIOID, MU; RNA, MESSENGER; TIME FACTORS;

EID: 63849224120     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.108.053462     Document Type: Article

References (36)

1. Afify EA (2002) Turnover of mu-opioid receptors in neuroblastoma cells. Brain Res Mol Brain Res 106:83-87.
2. Ammon-Treiber S and Höllt V (2005) Morphine-induced changes of gene expression in the brain. Addict Biol 10:81-89.
3. Arvidsson U, Riedl M, Chakrabarti S, Lee JH, Nakano AH, Dado RJ, Loh HH, Law PY, Wessendorf MW, and Elde R (1995) Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord. J Neurosci 15:3328-3341.
4. Bernstein MA and Welch SP (1998) mu-Opioid receptor down-regulation and cAMP- dependent protein kinase phosphorylation in a mouse model of chronic morphine tolerance. Brain Res Mol Brain Res 55:237-242.
5. Bhargava HN and Gulati A (1990) Down-regulation of brain and spinal cord muopiate receptors in morphine tolerant-dependent rats. Eur J Pharmacol 190:305311.
6. Binyaminy B, Gafni M, Shapira M, and Sarne Y (2008) Agonist-specific down regulation of mu-opioid receptors: Different cellular pathways are activated by different opioid agonists. Life Sci 82:831-839.
7. Boyd SD (2008) Everything you wanted to know about small RNA but were afraid to ask. Lab Invest 88:569-578.
8. Brodsky M, Elliott K, Hynansky A, and Inturrisi CE (1995) CNS levels of mu opioid receptor (MOR-1) mRNA during chronic treatment with morphine or naltrexone. Brain Res Bull 38:135-141.
9. Castelli MP, Melis M, Mameli M, Fadda P, Diaz G, and Gessa GL (1997) Chronic morphine and naltrexone fail to modify mu-opioid receptor mRNA levels in the rat brain. Brain Res Mol Brain Res 45:149-153.
10. Chakrabarti S, Law PY, and Loh HH (1995) Neuroblastoma Neuro2A cells stably expressing a cloned mu-opioid receptor: a specific cellular model to study acute and chronic effects of morphine. Brain Res Mol Brain Res 30:269 -278.
11. Choi HS, KimCS, HwangCK, SongKY, LawPY, WeiLN, and LohHH (2007) Novel function of the poly(C)-binding protein alpha CP3 as a transcriptional repressor of the mu opioid receptor gene. FASEB J 21:3963-3973.
12. Davis BN, Hilyard AC, Lagna G, and Hata A (2008) SMAD proteins control DRO-SHA-mediated microRNA maturation. Nature 454:56 -61.
13. del Prete MJ, Vernal R, Dolznig H, Müllner EW, and Garcia-Sanz JA (2007) Isolation of polysome-bound mRNA from solid tissues amenable for RT-PCR and profiling experiments. RNA 13:414-421.
14. Ding XC, Weiler J, and GroBßhans H (2009) Regulating the regulators: mechanisms controlling the maturation of microRNAs. Trends Biotechnol 27:27-36.
15. Duttaroy A and Yoburn BC (1995) The effect ofintrinsic efficacy on opioid tolerance. Anesthesiology 82:1226-1236.
16. Hitzemann RJ, Hitzemann BA, and Loh HH (1974) Binding of 3H-naloxone in the mouse brain: effect of ions and tolerance development. Life Sci 14:2393-2404.
17. Hwang CK, Kim CS, Choi HS, McKercher SR, and Loh HH (2004) Transcriptional regulation of mouse μ opioid receptor gene by PU. 1. J Biol Chem 279:1976419774.
18. Im HJ, Smirnov D, Yuhi T, Raghavan S, Olsson JE, Muscat GE, Koopman P, and Loh HH (2001) Transcriptional modulation of mouse mu-opioid receptor distal promoter activity by Sox18. Mol Pharmacol 59:1486-1496.
19. Kieffer BL (1995) Recent advances in molecular recognition and signal transduction of active peptides: receptors for opioid peptides. Cell Mol Neurobiol 15:615-635.
20. Kim CS, Choi HS, Hwang CK, Song KY, Lee BK, Law PY, Wei LN, and Loh HH(2006) Evidence of the neuron-restrictive silencer factor (NRSF) interaction with Sp3 and its synergic repression to the mu opioid receptor (MOR) gene. Nucleic Acids Res 34:6392-6403.
21. Koch T, Kroslak T, Mayer P, Raulf E, and Höillt V (1997) Site mutation in the rat mu-opioid receptor demonstrates the involvement of calcium/calmodulin- dependent protein kinase II in agonist-mediated desensitization. J Neurochem 69:1767-1770.
22. Kramer HK and Simon EJ (1999) Role of protein kinase C (PKC) in agonist-induced mu-opioid receptor down-regulation: II. Activation and involvement of the alpha, epsilon, and zeta isoforms of PKC. J Neurochem 72:594-604.
23. Lin H, Huganir R, and Liao D (2004) Temporal dynamics of NMDA receptor-induced changes in spine morphology and AMPA receptor recruitment to spines. Biochem Biophys Res Commun 316:501-511.
24. Schmidt H, Schulz S, Klutzny M, Koch T, Händel M, and Höllt V (2000) Involvement of mitogen-activated protein kinase in agonist-induced phosphorylation of the mu-opioid receptor in HEK 293 cells. J Neurochem 74:414-422.
25. Shen J, Benedict Gomes A, Gallagher A, Stafford K, and Yoburn BC (2000) Role of cAMP-dependent protein kinase (PKA) in opioid agonist-induced mu-opioid receptor downregulation and tolerance in mice. Synapse 38:322-327.
26. Song KY, Hwang CK, Kim CS, Choi HS, Law PY, Wei LN, and Loh HH (2007) Translational repression of mouse mu opioid receptor expression via leaky scanning. Nucleic Acids Res 35:1501-1513.
27. Tao PL, Han KF, Wang SD, Lue WM, Elde R, Law PY, and Loh HH (1998) Immu- nohistochemical evidence of down-regulation of mu-opioid receptor after chronic PL-017 in rats. Eur J Pharmacol 344:137-142.
28. Whistler JL, Chuang HH, Chu P, Jan LY, and von Zastrow M (1999) Functional dissociation of mu opioid receptor signaling and endocytosis: implications for the biology of opiate tolerance and addiction. Neuron 23:737-746.
29. Woods K, Thomson JM, and Hammond SM (2007) Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors. J Biol Chem 282:2130 -2134.
30. Wu EH and Wong YH (2005) Activation of delta-, kappa-, and mu-opioid receptors induces phosphorylation of tuberin in transfected HEK 293 cells and native cells. Biochem Biophys Res Commun 334:838-844.
31. Wu Q, Law PY, Wei LN, and Loh HH (2008) Post-transcriptional regulation of mouse μ-opioid receptor (MOR1) via its 3'′ untranslated region: a role for microRNA23b.FASEB J 22:4085-4095.
32. Yabaluri N and Medzihradsky F (1997) Down-regulation of mu-opioid receptor by full but not partial agonists is independent of G protein coupling. Mol Pharmacol 52:896 -902.
33. Yamamoto J, Kawamata T, Niiyama Y, Omote K, and Namiki A (2008) Down- regulation of mu opioid receptor expression within distinct subpopulations of dorsal root ganglion neurons in a murine model of bone cancer pain. Neuroscience151:843-853.
34. Yoburn BC, Billings B, and Duttaroy A (1993) Opioid receptor regulation in mice. J Pharmacol Exp Ther 265:314-320.
35. Zadina JE, Chang SL, Ge LJ, and Kastin AJ (1993) Mu opiate receptor down- regulation by morphine and up-regulation by naloxone in SH-SY5Y human neuroblastoma cells. J Pharmacol Exp Ther 265:254 -262.
36. Zaki PA, Keith DE Jr, Brine GA, Carroll FI, and Evans CJ (2000) Ligand-induced changes in surface mu-opioid receptor number: relationship to G protein activation? J Pharmacol Exp Ther 292:1127-1134.